Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person19
Cantor Equity Partners I, Inc.
Company
Cantor Equity Partners IV, Inc.
Company
Cantor Equity Partners V, Inc.
Company
Cantor Equity Partners III, Inc.
Company
Cantor Equity Partners VII, Inc.
Company
PJT Partners Inc.
Company
LFTD PARTNERS INC.
Company
CDT Equity Inc.
Company
Carlyle Private Equity Partners Fund, L.P.
Company
Surgery Partners, Inc.
Company
NewLake Capital Partners, Inc.
Company
Park Dental Partners, Inc.
Company
P3 Health Partners Inc.
Company
Farmland Partners Inc.
Company
Construction Partners, Inc.
Company
Green Brick Partners, Inc.
Company
Partners Group Private Equity Fund, LLC
Company
Phoenix Education Partners, Inc.
Company
CAS Investment Partners, LLC
Company
Primary record11
CTO Realty Growth, Inc. filed 8-K
Item 8.01 Other Events. On October 28, 2026, CTO Realty Growth, Inc. (the “Company”) entered into an equity distribution agreement, in substantially the form attached as Exhibit 1.1 to this Current Report on Form 8-K, an
Alpine Income Property Trust, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Third Amendment to Amended and Restated Agreement of Limited Partnership of Alpine Income Property OP, LP In connection with the Preferred Offering (as defined below)
Cantor Equity Partners VII, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Directors. Effective October 14, 2026, the b
Cantor Equity Partners V, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Directors. Effective October 14, 2026, the b
Atrium Therapeutics, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement On October 7, 2026, Atrium Therapeutics, Inc. (the Company ) entered into a securities purchase agreement (the Securities Purchase Agree
CANTOR FITZGERALD, L. P. filed SCHEDULE 13D/A
(the "SEC") on March 26, 2021 (the "Original Schedule 13D"), as amended by Amendment No. 1 to the Original Schedule 13D filed with the SEC on December 1, 2023 ("Amendment No. 1"), Amendment No. 2 to the Original Schedule
Cantor Equity Partners IV, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Directors. Effective August 25, 2026, the bo
BSTR Holdings, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information contained in Item 1.02 of this Current Report on Form 8-K with respect to the Termination and Release Agreement (as defined below) is incorporated by
BSTR Newco, LLC filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information contained in Item 1.02 of this Current Report on Form 8-K with respect to the Termination and Release Agreement (as defined below) is incorporated by
Cantor Equity Partners I, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information contained in Item 1.02 of this Current Report on Form 8-K with respect to the Termination and Release Agreement (as defined below) is incorporated by
Cantor Equity Partners I, Inc. filed SCHEDULE 13G/A
0001905106-26-000125.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001905106 XXXXXXXX LIVE 2 Class A common stock 06/30/2026 0002027708 Cantor Equity Partners I, Inc. G1827K107 110 East 59th Stree